DCTA Stock Overview
Directa Plus Plc manufactures and sells graphene-based products for industrial and commercial applications in Italy and internationally.
No risks detected for DCTA from our risk checks.
Directa Plus Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||UK£1.52|
|52 Week High||UK£1.78|
|52 Week Low||UK£0.73|
|1 Month Change||12.59%|
|3 Month Change||18.29%|
|1 Year Change||91.20%|
|3 Year Change||204.00%|
|5 Year Change||23.08%|
|Change since IPO||44.08%|
Recent News & Updates
Directa Plus Plc (LON:DCTA) Shares Could Be 31% Below Their Intrinsic Value Estimate
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Directa Plus Plc...
Is Directa Plus (LON:DCTA) Using Too Much Debt?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
|DCTA||GB Chemicals||GB Market|
Return vs Industry: DCTA exceeded the UK Chemicals industry which returned 26.2% over the past year.
Return vs Market: DCTA exceeded the UK Market which returned 10.5% over the past year.
|DCTA Average Weekly Movement||6.1%|
|Chemicals Industry Average Movement||7.0%|
|Market Average Movement||4.9%|
|10% most volatile stocks in GB Market||9.9%|
|10% least volatile stocks in GB Market||2.6%|
Stable Share Price: DCTA is not significantly more volatile than the rest of UK stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: DCTA's weekly volatility (6%) has been stable over the past year.
About the Company
Directa Plus Plc manufactures and sells graphene-based products for industrial and commercial applications in Italy and internationally. It operates through Textile, Environmental, and Others segments. The company offers its products under the G+ brand name.
Directa Plus Fundamentals Summary
|DCTA fundamental statistics|
Is DCTA overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|DCTA income statement (TTM)|
|Cost of Revenue||€2.61m|
Last Reported Earnings
Jun 30, 2021
Next Earnings Date
|Earnings per share (EPS)||-0.055|
|Net Profit Margin||-44.24%|
How did DCTA perform over the long term?See historical performance and comparison
Is Directa Plus undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: DCTA (£1.52) is trading below our estimate of fair value (£2.25)
Significantly Below Fair Value: DCTA is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: DCTA is unprofitable, so we can't compare its PE Ratio to the UK Chemicals industry average.
PE vs Market: DCTA is unprofitable, so we can't compare its PE Ratio to the UK market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate DCTA's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: DCTA is overvalued based on its PB Ratio (13.2x) compared to the GB Chemicals industry average (2.3x).
How is Directa Plus forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: DCTA is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (0.9%).
Earnings vs Market: DCTA is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: DCTA's is expected to become profitable in the next 3 years.
Revenue vs Market: DCTA's revenue (40.9% per year) is forecast to grow faster than the UK market (4.8% per year).
High Growth Revenue: DCTA's revenue (40.9% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if DCTA's Return on Equity is forecast to be high in 3 years time
How has Directa Plus performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: DCTA is currently unprofitable.
Growing Profit Margin: DCTA is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: DCTA is unprofitable, but has reduced losses over the past 5 years at a rate of 11.2% per year.
Accelerating Growth: Unable to compare DCTA's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: DCTA is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (35.2%).
Return on Equity
High ROE: DCTA has a negative Return on Equity (-31.54%), as it is currently unprofitable.
How is Directa Plus's financial position?
Financial Position Analysis
Short Term Liabilities: DCTA's short term assets (€9.5M) exceed its short term liabilities (€2.3M).
Long Term Liabilities: DCTA's short term assets (€9.5M) exceed its long term liabilities (€3.0M).
Debt to Equity History and Analysis
Debt Level: DCTA has more cash than its total debt.
Reducing Debt: DCTA's debt to equity ratio has increased from 3% to 18.4% over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: DCTA has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if DCTA has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.
What is Directa Plus's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate DCTA's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate DCTA's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if DCTA's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if DCTA's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of DCTA's dividend in 3 years as they are not forecast to pay a notable one for the UK market.
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Giulio Cesareo (65 yo)
Mr. Giulio Giuseppe Cesareo is a Co-founder of Directa Plus S.p.A. and serves as its Chief Executive Officer and President. Mr. Cesareo Founded Directa Plus Plc in 2005 and serves as its Chief Executive Of...
CEO Compensation Analysis
Compensation vs Market: Giulio's total compensation ($USD563.17K) is above average for companies of similar size in the UK market ($USD322.63K).
Compensation vs Earnings: Giulio's compensation has increased whilst the company is unprofitable.
Experienced Board: DCTA's board of directors are considered experienced (5.7 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Directa Plus Plc's employee growth, exchange listings and data sources
- Name: Directa Plus Plc
- Ticker: DCTA
- Exchange: AIM
- Founded: 2003
- Industry: Specialty Chemicals
- Sector: Materials
- Market Cap: UK£93.275m
- Shares outstanding: 61.37m
- Website: https://www.directa-plus.com
Number of Employees
- Directa Plus Plc
- ComoNExT Science Park
- Via Cavour 2
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/12/07 23:17|
|End of Day Share Price||2021/12/07 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.